Persistent Coronavirus Disease 2019 (COVID-19) in an Immunocompromised Host Treated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific Monoclonal Antibodies.
Bailly B, Péré H, Veyer D, Berceanu A, Daguindau E, Roux P, Hermine O, de Lamballerie X, Bastard P, Lacombe K, Autran B, Angelot Delettre F, Laurent Casanova J, Imbeaud S, Laure Clairet A, Kroemer M, Spehner L, Robillard N, Puech J, Marty-Quinternet S, Lepiller Q, Chirouze C, Bouiller K.
Bailly B, et al.
Clin Infect Dis. 2022 May 3;74(9):1706-1707. doi: 10.1093/cid/ciab868.
Clin Infect Dis. 2022.
PMID: 34598278
Free PMC article.
No abstract available.